Alexandria Real Estate Equities
ARE
#2282
Rank
A$11.96 B
Marketcap
A$69.51
Share price
-0.39%
Change (1 day)
-45.57%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Alexandria Real Estate Equities (ARE) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$22.16 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's total liabilities are A$22.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Alexandria Real Estate Equities - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$22.28 B-8.39%
2024-12-31A$24.32 B17.13%
2023-12-31A$20.76 B10.06%
2022-12-31A$18.86 B22.29%
2021-12-31A$15.42 B26.43%
2020-12-31A$12.20 B3.9%
2019-12-31A$11.74 B25.95%
2018-12-31A$9.32 B29.54%
2017-12-31A$7.19 B4.37%
2016-12-31A$6.89 B9.56%
2015-12-31A$6.29 B21.93%
2014-12-31A$5.16 B29.73%
2013-12-31A$3.98 B13.43%
2012-12-31A$3.50 B14.56%
2011-12-31A$3.06 B6.59%
2010-12-31A$2.87 B-15.38%
2009-12-31A$3.39 B-29.33%
2008-12-31A$4.80 B33.9%
2007-12-31A$3.58 B28.13%
2006-12-31A$2.80 B35.52%
2005-12-31A$2.06 B27.79%
2004-12-31A$1.61 B57.08%
2003-12-31A$1.02 B-13.84%
2002-12-31A$1.19 B-3.1%
2001-12-31A$1.23 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
A$165.82 B 648.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$155.45 B 601.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$120.38 B 443.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$53.94 B 143.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$5.56 B-74.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$93.66 B 322.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$6.02 B-72.80%๐Ÿ‡บ๐Ÿ‡ธ USA